A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$46.40.31 (0.67%)
NVS$59.921.94 (3.35%)
SNY$36.210.2 (0.56%)
GSK$47.66-1 (-2.06%)
Stem Cell Transplant Information Center
Latest Stem Cell Transplant News
Statins May Reduce Acute Graft-versus-host Disease (6/17/2008)

No Survival Advantage for High-dose Chemotherapy with Autologous Stem Cell Support for Localized Breast Cancer (12/18/2007)

Prochymal Receives Fast-Track Status for Initial Treatment of Acute GVHD (12/13/2007)

Bexxar® Plus BEAM and Autologous Stem Cells for Relapsed Non-Hodgkin’s Lymphoma (NHL) Very Effective (12/10/2007)

Umbilical Cord Blood Transplantation with Reduced Intensity Regimen Effective (11/14/2007)

More Stem Cell Transplant News »

More Stem Cell Transplant News »
Coming Soon
Submit an Editorial
CME
Conference Coverage

30th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT)
March 28-31, 2004 -- Barcelona, Spain

45th Annual Meeting of the American Society of Hematology
December 6-9, 2003 -- San Diego, CA

29th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT)
July 20-23, 2003 -- Istanbul, Turkey

44th Annual Meeting of the American Society of Hematology
December 6-10, 2002 -- Philadelphia, PA

7th Congress of the European Hematology Association
June 6, 2002 -- Florence, Italy

28th Annual Meeting of the European Group for Blood and Marrow Transplantation
March 24-27, 2002 -- Montreux, Switzerland

43rd Annual Meeting of The American Society of Hematology
December 7 - 11, 2001 -- Orlando, Florida
Current Topics in Oncology

Reduced Intensity Stem Cell Transplants To Treat Malignant Disease - A Review
Author: John  Barrett MD, FRCP, FRC Path., Chief, Stem Cell Allotransplanation Unit, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA

High-Dose Chemotherapy for Breast Cancer: The French Pegase Experience

 

1 Donor Lymphocyte Infusions to Treat Hematologic Malignancies in Relapse After Allogeneic Blood or Marrow Transplantation (5/13/2004)

1 Abstract and Introduction (5/13/2004)

1 Abstract and Introduction (5/13/2004)
Stem Cell Transplant Drug Pipeline
What's in the pipeline for Stem Cell Transplant.
Learn More »
Newsletters
Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
Learn More »
Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.